Angiogenic cell therapy for hepatic fibrosis

スポンサーリンク

概要

• 論文の詳細を見る
• 2006-03-01

著者

• UENO Takato

  Research Center for Innovative Cancer Therapy, Kurume University

• NAKAMURA Toru

  Research Center for Innovative Cancer Therapy, Kurume University

• TORIMURA Takuji

  Research Center for Innovative Cancer Therapy, Kurume University

• SATA Michio

  Research Center for Innovative Cancer Therapy, Kurume University

• Sakata M

  Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine

• Sata Michio

  久留米大学 大学院医学研究科消化器疾患情報講座

• Sata Michio

  京都府立医科大学 消化器内科学

• Sata Michio

  大腸肛門病センターくるめ病院

• Ueno Takato

  Research Center For Innovative Cancer Therapy Kurume University

• Ueno Takato

  久留米大学 医学部消化器内科

• Ueno Takato

  Research Center For Innovative Cancer Therapy And Second Department Of Internal Medicine Kurume Univ

• Ueno Takato

  Second Department Of Medicine Kurume University School Of Medicine

• Sata Michio

  久留米大学 医学部免疫学講座

• Sata Michio

  久留米大学 医学部消化器内科部門

• Sata Michio

  久留米大学先端癌治療研究センター

• Sata Michio

  久留米大学 消化器内科

• Torimura Takuji

  Research Center For Innovative Cancer Therapy Kurume University

• Murashima S

  Second Department Of Internal Medicine Kurume University School Of Medicine

• Sata Michio

  Research Center For Innovative Cancer Therapy And Second Department Of Internal Medicine Kurume Univ

• Nakamura Toru

  Research Center For Innovative Cancer Therapy Kurume University

• Sata Michio

  2nd Department Of Medicine Kurume University School Of Medicine

• Sata Michio

  Departments Of Internal Medicine Kurume University School Of Medicine

• Murashima Shiroh

  Second Department Of Internal Medicine Kurume University School Of Medicine

関連論文

• Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease
• Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan
• Human primary cultured hepatic stellate cells can be cryopreserved
• High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma
• Case-control study for the identification of virological factors associated with fulminant hepatitis B
• Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients
• Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis
• Periostin and bone marrow fibrosis
• Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
• Keratin inclusions alter cytosolic protein localization in hepatocytes
• Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
• Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
• Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
• New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
• Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
• Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
• Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice
• A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
• Angiogenic cell therapy for hepatic fibrosis
• Timing of interferon therapy and sources of infection in patients with acute hepatitis C
• Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
• A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
• Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma
• Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil
• Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
• Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
• A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
• Unusual hyperbilirubinemia associated with bacterial pneumonia and acute myeloid leukemia
• Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis : A Case Report
• Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases
• Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection
• Impaired Gastric Motility in Patients with Functional Dyspepsia
• Improvement of gastric motility by hemodialysis in patients with chronic renal failure
• Effects of endothelin-1 on the membrane potential and slow waves in circular smooth muscle of rat gastric antrum
• Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
• Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
• Endotoxin increases paracellular permeability of isolated rat hepatocyte couplets
• High prevalence of anticardiolipin antibodies in hepatitis C virus infection : lack of effects on thrombocytopenia and thrombotic complications
• Systemic Sclerosis Associated with Diabetes Insipidus
• Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
• ENDOSCOPIC RETRIEVAL OF MIGRATED PLASTIC STENT INTO BILE DUCT OR PANCREATIC PSEUDOCYST
• Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
• Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
• GB virus C (GBV-C)/hepatitis G virus (HGV) infection in a hepatitis C virus hyper-endemic area in Japan
• Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene
• Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
• OVEREXPRESSION OF MEMBRANE-TYPE 1 MATRIX METALLOPROTEINASE (MT1-MMP), MATRIX METALLOPRATEINASE-2 (MMP-2) IS ASSOCIATED WITH TUMOR DEVELOPMENT IN HEPATOCELLULAR CARCINOMA (HCC).
• ANTI-TGF-β INTERVENTION INHIBITS PROGRESSION OF HEPATIC FIBROSIS
• RHO SIGNALING IS REQUIRED FOR MECHANICAL STRETCH-INDUCED TGF-β PRODUCTION IN HEPATIC STELLATE CELLS
• CHANGES OF CELL, EXTRACELLULAR MATRIX, APOPTOSIS AND ANGlOGENESIS IN HEPATIC INJURY AND REPAIR
• Two-year follow-up study after treatment with lamivudine for chronic hepatitis B : seven cases reported
• Development of a new method for detecting a mutation in the gene encoding hepatitis B virus reverse transcriptase active site (YMDD motif)
• Erythropoietic protoporphyria with fatal liver failure
• Intracellular traffic of asialoglycoproteins depends on vacuolar pH in polarized isolated rat hepatocyte couplets
• Antiphospholipid syndrome modifies the clinical features of systemic lupus erythematosus
• Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
• Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
• In Vitro Study of Neutrophil Apoptosis in Liver Cirrhosis
• Hepatitis B virus genotype G is an extremely rare genotype in Japan
• Involvement of GBV-C/HGV in liver diseases in Japan
• High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
• Lack of detection of hepatitis C virus replicative intermediate in abdominal lymph nodes
• Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
• Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
• Dextromethorphan for neuropathic pain with Churg-Strauss syndrome
• Polyarteritis nodosa with mesenteric aneurysms demonstrated by angiography : report of a case and successful treatment of the patient with prednisolone and cyclophosphamide
• Pulse Intravenous Cyclophosphamide Treatment for Steroid-resistant Interstitial Pneumonitis Associated with Polymyositis
• Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan
• β1-Integrin mediates cell adhesion, haptotaxis, and chemokinesis of hepatoma cells
• Unusual Accumulation of Glycogen in Liver Parenchymal Cells in a Patient with Anorexia Nervosa
• Long-term improvement of hepatic fibrosis in chronic hepatitis C treated with interferon-α
• Effects of OK-432 on matrix metalloproteinase-9 expression and activity in rat cultured Kupffer cells
• Clinical usefulness of serum HBV DNA measurement with a non radioactive chemiluminescence method
• A pilot study of natural interferon γ therapy for chronic hepatitis C
• Does Hepatocellular Carcinoma Develop After Treatment of Wegener's Granulomatosis with Cyclophosphamide?
• Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan
• Liver-Associated Natural Killer Activity in Cirrhotic Rats
• Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA
• GASTRIC SCHWANNOMA WITH ADJACENT EXTERNAL PROGRESSION HARBORED ABERRANT NF2 GENE
• High incidence of extrahepatic manifestations in an HCV hyperendemic area
• Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
• Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
• Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
• Gender difference in alcoholic liver desease in Japan-an analysis based on histological findings
• A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
• Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan
• Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
• GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
• AN ENDOCRINE CELL CARCINOMA WITH GASTRIC-AND-INTESTINAL MIXED PHENOTYPE ADENOCARCINOMA COMPONENT IN THE STOMACH
• Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD : a pilot study
• Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
• Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
• Association between type 2 diabetes genetic susceptibility loci and visceral and subcutaneous fat area as determined by computed tomography
• Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1
• Genetic variations in the CYP17A1 and NT5C2 genes are associated with a reduction in visceral and subcutaneous fat areas in Japanese women
• Computed tomography analysis of the association between the SH2B1 rs7498665 single-nucleotide polymorphism and visceral fat area
• Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population
• Polymorphisms in NRXN3, TFAP2B, MSRA, LYPLAL1, FTO and MC4R and their effect on visceral fat area in the Japanese population
• Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population
• Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy

もっと見る 閉じる

スポンサーリンク